Doxazosin
NDC 42291-260, Doxazosin, tablet, from AvKARE.
- Product NDC
- 42291-260
- Status
- Listed
- Labeler
- AvKARE
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA075580
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42291-260 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DOXAZOSIN MESYLATE8 mg/1
Pharmacologic classes
Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42291-260-01 | 42291026001 | 100 TABLET in 1 BOTTLE (42291-260-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e3d381c1-3b2f-af70-f4e6-08d6202eed25
Use it
Look up 42291-260 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42291-260 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42291-260. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.